Description
Erbitux 5 mg/mL solution for infusion is a targeted anticancer medication containing cetuximab, a monoclonal antibody used to treat specific metastatic colorectal cancers (KRAS/RAS wild-type) and squamous cell head and neck cancers. It works by inhibiting the epidermal growth factor receptor (EGFR), usually administered weekly via intravenous infusion.
Additional information
| Brand | Erbitux |
|---|---|
| Generic name | Cetuximab for infusion |
| Form | Parenteral |
| Strength | 5ml/ml |
| Packing | 20ml/vial |
| Manufacturer | Merck |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
Reviews
There are no reviews yet.